Back to Search
MIGUEL PAPPOLLA, MD, PHD
MD, PHD
Interventional Pain Medicine Physician
NPI: 1528051646Individual
Specialties, Licenses & Credentials
Neurology Physician
Psychiatry & Neurology — Neurology
Code: 2084N0400X
J5436(TX)
Interventional Pain Medicine PhysicianPrimary
Pain Medicine — Interventional Pain Medicine
Code: 208VP0014X
J5436(TX)
Research & Publications (20)
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.
PMID 19160110·Free Radic Res·2009
7-preclinical
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
PMID 19086266·Neurology·2008
8-other
Beta-secretase: structure, function, and evolution.
PMID 18673212·CNS Neurol Disord Drug Targets·2008
6-review
Value in development of a TAPIR-like mouse monoclonal antibody to Abeta.
PMID 18663823·J Alzheimers Dis·2008
7-preclinical
A unique case of limb-girdle muscular dystrophy type 2A carrying novel compound heterozygous mutations in the human CAPN3 gene.
PMID 17594342·Eur J Neurol·2007
5-case
Insulysin cleaves the APP cytoplasmic fragment at multiple sites.
PMID 17701350·Neurochem Res·2007
7-preclinical
Fine-tuning the amphiphilicity: a crucial parameter in the design of potent alpha-phenyl-N-tert-butylnitrone analogues.
PMID 17649989·J Med Chem·2007
7-preclinical
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
PMID 16640342·J Med Chem·2006
7-preclinical
Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.
PMID 16516482·Neurobiol Dis·2006
7-preclinical
Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice.
PMID 16503402·Biochim Biophys Acta·2006
7-preclinical
Mitochondrial medicine: neuroprotection and life extension by the new amphiphilic nitrone LPBNAH acting as a highly potent antioxidant agent.
PMID 16135084·J Neurochem·2005
4-observational
Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.
PMID 16075376·Cell Mol Neurobiol·2005
6-review
Melatonin relieves the neural oxidative burden that contributes to dementias.
PMID 15681808·Ann N Y Acad Sci·2004
6-review
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
PMID 12876705·Magn Reson Med·2003
7-preclinical
Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol.
PMID 14501024·J Mol Neurosci·2003
7-preclinical
Beta-secretase processing of the Alzheimer's amyloid protein precursor (APP).
PMID 14501002·J Mol Neurosci·2003
7-preclinical
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology.
PMID 12874399·Neurology·2003
4-observational
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease.
PMID 12753069·J Neurochem·2003
7-preclinical
The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors.
PMID 12074096·J Pineal Res·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2646 S LOOP WEST STE 106
HOUSTON, TX 77054 - Phone
- (713) 661-0300
Quick Facts
- NPI
- 1528051646
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile